DOI,paper_doi,paper_title,count_atlas,Publication_PMID,Publication_link_x,count_lnpdb,Index,LNP_ID,Experiment_ID,Formulation_ID,IL_name,IL_SMILES,IL_protonated_SMILES,IL_head_name,IL_head_SMILES,IL_linker_name,IL_linker_SMILES,IL_tail1_name,IL_tail1_SMILES,IL_tail2_name,IL_tail2_SMILES,IL_tail3_name,IL_tail3_SMILES,IL_tail4_name,IL_tail4_SMILES,IL_molratio,IL_to_nucleicacid_massratio,IL_to_nucleicacid_chargeratio,HL_name,HL_SMILES,HL_molratio,CHL_name,CHL_SMILES,CHL_molratio,PEG_name,PEG_SMILES,PEG_molratio,fifthcomponent_name,fifthcomponent_SMILES,fifthcomponent_molratio,Aqueous_buffer,Dialysis_buffer,Mixing_method,Model,Model_type,Model_target,Route_of_administration,Cargo,Cargo_type,Dose_ug_nucleicacid,Experiment_method,Experiment_batching,Experiment_value,Publication_link_y,Heavy.Atoms,Rings,Aromatic.Rings,Rotatable.Bonds,van.der.Waals.Molecular.Volume,Topological.Polar.Surface.Area,Hydrogen.Bond.Donors,Hydrogen.Bond.Acceptors,LogP,Molar.Refractivity,Fraction.sp3.Carbons,sp3.Carbons,Nitrogen.Count,Molecular.Weight,has_ester,has_carbonate,has_disulfide
10.1039/d5nr00433k,10.1039/d5nr00433k,"PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery",25,40131321.0,https://doi.org/10.1039/D5NR00433K,8,19017,LNP_0019017,LL_2025,LL_2025_F1,OF-02,CCCCC/C=C\C/C=C\CCCCCCC(O)CN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CCCCC1C(NC(C(N1)=O)CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)=O,CCCCC/C=C\C/C=C\CCCCCCC(O)C[N+](CC(O)CCCCCC/C=C\C/C=C\CCCCC)(CCCCC1C(=O)NC(CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)C(=O)N1)[H],,,,,,,,,,,,,40.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,30.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,28.5,DMG-PEG2000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.5,None,,0.0,citrate,PBS,handmixed,in_vivo,Mouse_BALBc,muscle,intramuscular,mRNA,hEPO,0.1,protein_adundance_normalized,individual,1.239811228,https://doi.org/10.1039/D5NR00433K,94,1,0,70,1313.171189,145.6,6,8,21.0514,407.4346,0.785714286,6,4,1314.162,False,False,False
10.1039/d5nr00433k,10.1039/d5nr00433k,"PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery",25,40131321.0,https://doi.org/10.1039/D5NR00433K,8,19018,LNP_0019018,LL_2025,LL_2025_F2,OF-02,CCCCC/C=C\C/C=C\CCCCCCC(O)CN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CCCCC1C(NC(C(N1)=O)CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)=O,CCCCC/C=C\C/C=C\CCCCCCC(O)C[N+](CC(O)CCCCCC/C=C\C/C=C\CCCCC)(CCCCC1C(=O)NC(CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)C(=O)N1)[H],,,,,,,,,,,,,40.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,30.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,28.5,DMG-PEG5000,O=C(CCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.5,None,,0.0,citrate,PBS,handmixed,in_vivo,Mouse_BALBc,muscle,intramuscular,mRNA,hEPO,0.1,protein_adundance_normalized,individual,1.745856628,https://doi.org/10.1039/D5NR00433K,94,1,0,70,1313.171189,145.6,6,8,21.0514,407.4346,0.785714286,6,4,1314.162,False,False,False
10.1039/d5nr00433k,10.1039/d5nr00433k,"PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery",25,40131321.0,https://doi.org/10.1039/D5NR00433K,8,19019,LNP_0019019,LL_2025,LL_2025_F3,OF-02,CCCCC/C=C\C/C=C\CCCCCCC(O)CN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CCCCC1C(NC(C(N1)=O)CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)=O,CCCCC/C=C\C/C=C\CCCCCCC(O)C[N+](CC(O)CCCCCC/C=C\C/C=C\CCCCC)(CCCCC1C(=O)NC(CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)C(=O)N1)[H],,,,,,,,,,,,,40.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,30.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,28.5,DPG-PEG2000,CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCC)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.5,None,,0.0,citrate,PBS,handmixed,in_vivo,Mouse_BALBc,muscle,intramuscular,mRNA,hEPO,0.1,protein_adundance_normalized,individual,-0.05060454,https://doi.org/10.1039/D5NR00433K,94,1,0,70,1313.171189,145.6,6,8,21.0514,407.4346,0.785714286,6,4,1314.162,False,False,False
10.1039/d5nr00433k,10.1039/d5nr00433k,"PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery",25,40131321.0,https://doi.org/10.1039/D5NR00433K,8,19020,LNP_0019020,LL_2025,LL_2025_F4,OF-02,CCCCC/C=C\C/C=C\CCCCCCC(O)CN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CCCCC1C(NC(C(N1)=O)CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)=O,CCCCC/C=C\C/C=C\CCCCCCC(O)C[N+](CC(O)CCCCCC/C=C\C/C=C\CCCCC)(CCCCC1C(=O)NC(CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)C(=O)N1)[H],,,,,,,,,,,,,40.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,30.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,28.5,DPG-PEG5000,CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCC)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.5,None,,0.0,citrate,PBS,handmixed,in_vivo,Mouse_BALBc,muscle,intramuscular,mRNA,hEPO,0.1,protein_adundance_normalized,individual,-0.632556749,https://doi.org/10.1039/D5NR00433K,94,1,0,70,1313.171189,145.6,6,8,21.0514,407.4346,0.785714286,6,4,1314.162,False,False,False
10.1039/d5nr00433k,10.1039/d5nr00433k,"PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery",25,40131321.0,https://doi.org/10.1039/D5NR00433K,8,19021,LNP_0019021,LL_2025,LL_2025_F5,OF-02,CCCCC/C=C\C/C=C\CCCCCCC(O)CN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CCCCC1C(NC(C(N1)=O)CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)=O,CCCCC/C=C\C/C=C\CCCCCCC(O)C[N+](CC(O)CCCCCC/C=C\C/C=C\CCCCC)(CCCCC1C(=O)NC(CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)C(=O)N1)[H],,,,,,,,,,,,,40.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,30.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,28.5,DSG-PEG2000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.5,None,,0.0,citrate,PBS,handmixed,in_vivo,Mouse_BALBc,muscle,intramuscular,mRNA,hEPO,0.1,protein_adundance_normalized,individual,0.07590681,https://doi.org/10.1039/D5NR00433K,94,1,0,70,1313.171189,145.6,6,8,21.0514,407.4346,0.785714286,6,4,1314.162,False,False,False
10.1039/d5nr00433k,10.1039/d5nr00433k,"PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery",25,40131321.0,https://doi.org/10.1039/D5NR00433K,8,19022,LNP_0019022,LL_2025,LL_2025_F6,OF-02,CCCCC/C=C\C/C=C\CCCCCCC(O)CN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CCCCC1C(NC(C(N1)=O)CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)=O,CCCCC/C=C\C/C=C\CCCCCCC(O)C[N+](CC(O)CCCCCC/C=C\C/C=C\CCCCC)(CCCCC1C(=O)NC(CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)C(=O)N1)[H],,,,,,,,,,,,,40.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,30.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,28.5,DSG-PEG5000,O=C(CCCCCCCCCCCCCCCCC)OCC(OC(CCCCCCCCCCCCCCCCC)=O)COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.5,None,,0.0,citrate,PBS,handmixed,in_vivo,Mouse_BALBc,muscle,intramuscular,mRNA,hEPO,0.1,protein_adundance_normalized,individual,-1.062695339,https://doi.org/10.1039/D5NR00433K,94,1,0,70,1313.171189,145.6,6,8,21.0514,407.4346,0.785714286,6,4,1314.162,False,False,False
10.1039/d5nr00433k,10.1039/d5nr00433k,"PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery",25,40131321.0,https://doi.org/10.1039/D5NR00433K,8,19023,LNP_0019023,LL_2025,LL_2025_F7,OF-02,CCCCC/C=C\C/C=C\CCCCCCC(O)CN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CCCCC1C(NC(C(N1)=O)CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)=O,CCCCC/C=C\C/C=C\CCCCCCC(O)C[N+](CC(O)CCCCCC/C=C\C/C=C\CCCCC)(CCCCC1C(=O)NC(CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)C(=O)N1)[H],,,,,,,,,,,,,40.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,30.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,28.5,DOG-PEG2000,CCCCCCCC/C=C\CCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCC)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.5,None,,0.0,citrate,PBS,handmixed,in_vivo,Mouse_BALBc,muscle,intramuscular,mRNA,hEPO,0.1,protein_adundance_normalized,individual,-0.581952209,https://doi.org/10.1039/D5NR00433K,94,1,0,70,1313.171189,145.6,6,8,21.0514,407.4346,0.785714286,6,4,1314.162,False,False,False
10.1039/d5nr00433k,10.1039/d5nr00433k,"PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery",25,40131321.0,https://doi.org/10.1039/D5NR00433K,8,19024,LNP_0019024,LL_2025,LL_2025_F8,OF-02,CCCCC/C=C\C/C=C\CCCCCCC(O)CN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CCCCC1C(NC(C(N1)=O)CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)=O,CCCCC/C=C\C/C=C\CCCCCCC(O)C[N+](CC(O)CCCCCC/C=C\C/C=C\CCCCC)(CCCCC1C(=O)NC(CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC)C(=O)N1)[H],,,,,,,,,,,,,40.0,10.0,,DOPE,[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\\CCCCCCCC)=O)COC(CCCCCCC/C=C\\CCCCCCCC)=O,30.0,Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,28.5,DOG-PEG5000,CCCCCCCC/C=C\CCCCCCC(=O)OCC(COC(=O)CCCCCCC/C=C\CCCCCCC)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,1.5,None,,0.0,citrate,PBS,handmixed,in_vivo,Mouse_BALBc,muscle,intramuscular,mRNA,hEPO,0.1,protein_adundance_normalized,individual,-0.733765829,https://doi.org/10.1039/D5NR00433K,94,1,0,70,1313.171189,145.6,6,8,21.0514,407.4346,0.785714286,6,4,1314.162,False,False,False
